Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566850 · ClinicalTrials.gov registry record · NA
Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment
A NA study, sponsored by Ekso Bionics.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02566850: Clinical Trial NA study, sponsored by Ekso Bionics.
NCT02566850 is a NA study that was terminated before completion, run by Ekso Bionics. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566850, a NA study, was terminated before completion, sponsored by Ekso Bionics.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over an extended period, ranging from 12-42 months.
Primary Outcome
evaluate the safety of a subject walking with a lay spotter in a non-clinical environment
Interventions
- DEVICE Ekso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-07-25 |
| Phase | NA |
Why NCT02566850 stopped before completion
NCT02566850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Ekso is the first listed.
NCT02566850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566850 about?
NCT02566850 is a clinical study titled "Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment". The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over an extended period, ranging from 12-42 months.
What is the current status of trial NCT02566850?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-01. Estimated completion is 2017-07-25.
What interventions are being tested in trial NCT02566850?
The interventions under investigation include: Ekso (DEVICE).
Who is sponsoring clinical trial NCT02566850?
This trial is sponsored by Ekso Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02566850's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia